THE EFFECTS OF L-DOPA ON INVITRO DOPAMINE RELEASE FROM STRIATUM

被引:36
作者
SNYDER, GL
ZIGMOND, MJ
机构
[1] UNIV PITTSBURGH,DEPT BEHAV NEUROSCI,571A CRAWFORD HALL,PITTSBURGH,PA 15260
[2] UNIV PITTSBURGH,DEPT NEUROSCI,PITTSBURGH,PA 15260
关键词
6-Hydroxydopamine; Dopamine; In vitro; l-Dihydroxyphenylalanine; Slice; Striatum;
D O I
10.1016/0006-8993(90)90394-Q
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We have examined the effects of l-dihydroxyphenylalanine (l-DOPA) on endogenous dopamine (DA) and dihydroxyphenylacetic acid (DOPAC) efflux from superfused striatal slices prepared from adult male rats. Superfusion with l-DOPA (10 μM) caused a modest elevation in the tissue levels of DA and greatly increased the basal efflux and stimulation-evoked overflow of DA. Stimulation of slices under Ca2+-free conditions abolished DA overflow occurring in the absence of l-DOPA, but reduced DA overflow in the presence of l-DOPA by only 56%. Ca2+-independent DA release was not reduced by nomifensine. Destruction of DA terminals by pretreatment with 6-hydroxydopamine did not alter the capacity of l-DOPA to elevate tissue DA content. However, it attenuated the impact of l-DOPA on DA efflux, although this effect was somewhat smaller than was the apparent loss of DA terminals. These results suggest the following conclusions: (1) l-DOPA increases both the spontaneous and depolarization-induced release of DA; (2) some of the DA formed from l-DOPA can be released in response to depolarization by a process that does not involve either Ca2+-dependent exocytosis or reverse transport; and (3) most but not all of the DA efflux occurring in the presence of l-DOPA represents DA released from DA terminals. Furthermore, the observations suggest that the loss of DA terminals due to the progression of Parkinson's disease may be importantly involved in the gradual loss of clinical efficacy of the drug during chronic treatment. © 1990.
引用
收藏
页码:181 / 187
页数:7
相关论文
共 50 条
[41]   Enhancement of cytotoxicity and clastogenicity of L-DOPA and dopamine by manganese and copper [J].
Snyder, RD ;
Friedman, MB .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 1998, 405 (01) :1-8
[42]   Dopamine depletion and subsequent treatment with L-DOPA, but not the long-lived dopamine agonist pergolide, enhances activity of the Akt pathway in the rat striatum [J].
Bychkov, Evgeny ;
Ahmed, M. Rafiuddin ;
Dalby, Kevin N. ;
Gurevich, Eugenia V. .
JOURNAL OF NEUROCHEMISTRY, 2007, 102 (03) :699-711
[43]   DIFFERENTIAL EFFECT OF SYSTEMIC ADMINISTRATION OF BROMOCRIPTINE AND L-DOPA ON THE RELEASE OF ACETYLCHOLINE FROM STRIATUM OF INTACT AND 6-OHDA-TREATED RATS [J].
DEBOER, P ;
ABERCROMBIE, ED ;
HEERINGA, M ;
WESTERINK, BHC .
BRAIN RESEARCH, 1993, 608 (02) :198-203
[44]   Prenatal L-DOPA exposure produces lasting changes in brain dopamine content, cocaine-induced dopamine release and cocaine conditioned place preference [J].
Ren, Jia-Qian ;
Jiang, Yan ;
Wang, Zhihui ;
McCarthy, Deirdre ;
Rajadhyaksha, Anjali M. ;
Tropea, Thomas F. ;
Kosofsky, Barry E. ;
Bhide, Pradeep G. .
NEUROPHARMACOLOGY, 2011, 60 (2-3) :295-302
[45]   Renal effects of L-DOPA in heart failure [J].
Grossman, E ;
Shenkar, A ;
Peleg, E ;
Thaler, M ;
Goldstein, DS .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1999, 33 (06) :922-928
[46]   Neurotoxic effects of amphetamine plus L-DOPA [J].
Myers, CS ;
Halladay, AK ;
Widmer, DA ;
Wagner, GC .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1999, 23 (04) :731-740
[47]   L-DOPA STIMULATES C-FOS EXPRESSION IN DOPAMINE DENERVATED STRIATUM BY COMBINED ACTIVATION OF D-1 AND D-2 RECEPTORS [J].
MORELLI, M ;
COZZOLINO, A ;
PINNA, A ;
FENU, S ;
CARTA, A ;
DICHIARA, G .
BRAIN RESEARCH, 1993, 623 (02) :334-336
[48]   Effect of systemic L-DOPA administration on extracellular kynurenate levels in the rat striatum [J].
Wu, HQ ;
Rassoulpour, A ;
Schwarcz, R .
JOURNAL OF NEURAL TRANSMISSION, 2002, 109 (03) :239-249
[49]   Effect of systemic L-DOPA administration on extracellular kynurenate levels in the rat striatum [J].
H.-Q. Wu ;
A. Rassoulpour ;
R. Schwarcz .
Journal of Neural Transmission, 2002, 109 :239-249
[50]   Sodium nitroprusside stimulates L-DOPA release from striatal tissue through nitric oxide and cGMP [J].
Sanchez, JJ ;
Abreu, P ;
Gonzalez, MC .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 438 (1-2) :79-83